Scholar Rock Holding Corp
SRRK
24 insider filings · Latest: Apr 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 20 10:12 PM | Keith WoodsChief Operating Officer | Sale | 10,220 | $49.57 | $506.7K | 620,055(D) | View → |
| Apr 16, 2026 | Apr 20 10:10 PM | Akshay VaishnawDirector, President of R&D | Sale | 12,246 | $49.57 | $607.1K | 630,542(D) | View → |
| Apr 16, 2026 | Apr 20 10:09 PM | Vikas SinhaChief Financial Officer | Sale | 10,410 | $49.57 | $516.1K | 619,856(D) | View → |
| Apr 16, 2026 | Apr 20 10:08 PM | David HallalDirector, Chief Executive Officer | Sale | 30,615 | $49.57 | $1.5M | 1,639,034(D) | View → |
| Apr 6, 2026 | Apr 6 8:11 PM | Mohammed Qatanani | Proposed Sale | 23,408 | $50.01 | $1.2M | — | View → |
| Feb 23, 2026 | Feb 25 10:55 PM | Mo QatananiCHIEF SCIENTIFIC OFFICER | Sale | 8,484 | $47.07 | $399.4K | 98,445(D) | View → |
| Feb 23, 2026 | Feb 23 9:05 PM | Mohammed Qatanani | Proposed Sale | 8,484 | $48.32 | $409.9K | — | View → |
| Feb 17, 2026 | Feb 19 9:30 PM | Jing L. MarantzCHIEF MEDICAL OFFICER | Sale | 4,157 | $46.53 | $193.4K | 126,012(D) | View → |
| Feb 17, 2026 | Feb 19 9:30 PM | Junlin HoGENERAL COUNSEL | Sale | 9,580 | $46.53 | $445.7K | 241,545(D) | View → |
| Feb 17, 2026 | Feb 19 9:30 PM | Caryn ParlavecchioCHRO | Sale | 9,035 | $46.53 | $420.4K | 169,087(D) | View → |
| Feb 17, 2026 | Feb 19 9:30 PM | Mo QatananiCHIEF SCIENTIFIC OFFICER | Sale | 7,989 | $46.53 | $371.7K | 106,929(D) | View → |
| Jan 22, 2026 | Jan 23 9:30 PM | Mo QatananiCHIEF SCIENTIFIC OFFICER | Sale | 14,898 | $46.71 | $695.9K | 85,660(D) | View → |
| Jan 22, 2026 | Jan 22 9:14 PM | Mohammed Qatanani | Proposed Sale | 14,898 | $46.05 | $686.1K | — | View → |
| Jan 16, 2026 | Jan 22 12:52 AM | Mo QatananiCHIEF SCIENTIFIC OFFICER | Sale | 8,406 | $44.48 | $373.9K | 100,558(D) | View → |
| Jan 16, 2026 | Jan 22 12:51 AM | Caryn ParlavecchioCHRO | Sale | 6,600 | $44.48 | $293.6K | 148,864(D) | View → |
| Jan 16, 2026 | Jan 22 12:50 AM | Jing L. MarantzCHIEF MEDICAL OFFICER | Sale | 5,798 | $44.48 | $257.9K | 95,687(D) | View → |
| Jan 16, 2026 | Jan 22 12:50 AM | Junlin HoGENERAL COUNSEL | Sale | 8,016 | $44.48 | $356.5K | 214,553(D) | View → |
| Dec 16, 2025 | Dec 16 11:02 PM | Katie Peng | Proposed Sale | 1,006 | $45.24 | $45.5K | — | View → |
| Dec 4, 2025 | Dec 4 9:19 PM | Mohammed Qatanani | Proposed Sale | 149,574 | $43.01 | $6.4M | — | View → |
| Sep 22, 2025 | Sep 22 8:33 PM | Mohammed Qatanani | Proposed Sale | 3,353 | $30.67 | $102.8K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 24 8:05 PM | Kristina BurowDirector | Option Exercise | 89,800 | $26.78 | 0(D) | View → |
| Dec 11, 2025 | Feb 6 10:35 PM | Invus Global Management, LLC10% Owner | X | 1,575,008 | $7.35 | 0(D) | View → |